Skip to main content
ASND logo

Ascendis Pharma A/S

ASNDNASDAQHealthcareBiotechnology

$225.24Today:- (-)1Y +7.66%

As of Oct 16, 2026 close

Market cap
$15.48B
P/E (TTM)
18.23
Forward P/E
-
Dividend yield
-
52-week range
$186.05$282.15
Volume (live)
-
Avg. volume (3M)
857.03K

Ascendis Pharma A/S (ASND) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Ascendis Pharma A/S stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
(22 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$317.47
+40.95% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ASND Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Tazeen Ahmad
BofA Securities
BuyReiterates
$304.00
Luca Issi
RBC Capital
BuyMaintains
$290.00
Sean Laaman
Morgan Stanley
BuyReiterates
$273.00
Eliana Merle
Barclays
BuyMaintains
$329.00
Li Watsek
Cantor Fitzgerald
BuyMaintains
$300.00
Yun Zhong
Wedbush
BuyMaintains
$327.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$344.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$304.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$304.00
David Lebowitz
BMO Capital
BuyMaintains
$319.00
Jessica Fye
JP Morgan
BuyMaintains
-
Martin Auster
Raymond James
BuyMaintains
$287.00
David Lebowitz
BMO Capital
BuyMaintains
$319.00
Leland Gershell
Oppenheimer
BuyMaintains
$304.00 → $312.00
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$326.00
Faisal Khurshid
Jefferies
BuyMaintains
$333.00 → $330.00
Eric Joseph
Citi
BuyMaintains
$355.00 → $360.00
Derek Archila
Wells Fargo
BuyMaintains
$326.00
Yaron Werber
TD Cowen
BuyMaintains
$325.00 → $341.00
Luca Issi
RBC Capital
BuyMaintains
$280.00 → $290.00
Gavin Clark-Gartner
Evercore ISI Group
BuyMaintains
$329.00
Paul Choi
Goldman Sachs
BuyMaintains
$260.00 → $300.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ASND?

The analyst consensus rating for ASND is Buy, based on the latest ratings from 18 analysts over the last 90 days.

What is the average price target for ASND?

The average 12-month price target for ASND is $317.47, representing an upside of 40.9% from the Oct 16, 2026 close of $225.24.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.